Filter
173
Text search:
Anti-Tuberculosis
medicines
Featured
Recommendations
29
New Publications
54
Language
Document type
No document type
128
Studies & Reports
18
Guidelines
15
Manuals
7
Training Material
2
Situation Updates
2
Fact sheets
1
Countries / Regions
Western and Central Europe
9
Nepal
8
Zambia
7
Eastern Europe
7
India
6
Malawi
6
Namibia
6
Ethiopia
5
Kenya
5
Uganda
4
South Africa
4
Russia
4
Zimbabwe
3
Tanzania
3
Bangladesh
3
Myanmar / Burma
3
Nigeria
2
Rwanda
2
Asia
2
Burkina Faso
1
Liberia
1
Ghana
1
Pakistan
1
Afghanistan
1
Gambia
1
Mozambique
1
Eswatini/ Swaziland
1
Ukraine
1
Lesotho
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Bhutan
1
Poland
1
Timor Leste/ East Timor
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
67
Clinical Guidelines
28
Public Health
5
Women & Child Health
5
Capacity Building
3
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
TB
90
HIV
10
AMR
8
Pharmacy
5
NTDs
5
Polio
4
Refugee
3
COVID-19
2
Mental Health
1
Caregiver
1
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858–864.Namibia ranks among the 30 high TB burden countries worldwide. Here, we report results of the second nationwide anti-TB drug resistance survey. To assess the prevalence and trends of multidrug-resistant TB (MDR-TB) in Namibia.
From 2014 to 2015, pat
...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
Accessed November 2017
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a cruc
...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
J Nepal Health Res Counc 2013 May;11(24):198-204
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb
...
